DIN 02480824 — CABOMETYX 20 MG
CABOMETYX is a tablet of Cabozantinib marketed by IPSEN BIOPHARMACEUTICALS CANADA INC. The full Cabozantinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02480824
- Brand name
- CABOMETYX
- Active ingredient
- Cabozantinib
- Strength
- 20 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- IPSEN BIOPHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Multi-kinase inhibitor (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cabozantinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02480832 | CABOMETYX | 40 MG | TABLET | IPSEN BIOPHARMACEUTICALS CANADA INC | MARKETED |
| 02480840 | CABOMETYX | 60 MG | TABLET | IPSEN BIOPHARMACEUTICALS CANADA INC | MARKETED |